s6y
Company name or ticker
Search
Nurix Therapeutics, Inc.
POS AM
Post-effective amendment to a registration statement that is not immediately effective upon filing
Filed
Thursday, February 9, 2023
Accession number
0001193125-23-030326
Documents
Post-effective amendment to a registration statement that is not immediately effective upon filing
POS AM
Certifications, consents and other formalities
2
Legal opinion, Consent of experts
5.1
Legal opinion
EX-5.1
23.1
Consent of experts
EX-23.1
On sec.gov
Filing index
All files
Complete submission text
SGML header